Exosomes of mesenchymal stem cells delivered from methacrylated hyaluronic acid patch improve the regenerative properties of endothelial and dermal cells

Biomater Adv. 2022 Aug:139:213000. doi: 10.1016/j.bioadv.2022.213000. Epub 2022 Jun 25.

Abstract

Wound care management urgently needs the development of innovative smart wound dressings. The complexity of the wound often requires the use of personalized medication and the advent of three-dimensional (3D) bioprinting fits strongly with this need. In this view, in the present work a methacrylated hyaluronic acid (MeHA) bioink was tested for the fabrication of advanced smart patches as a delivery system of exosomes derived from human mesenchymal stem cells (hMSC-EXOs) suitable for wound healing purposes. MeHA patches were realized by 3D bioprinting technique and they were loaded with hMSC-EXOs. The 3D printed MeHA patches revealed improved mechanical performance, appropriate swelling ratio, extended degradation time, and suitable biocompatibility. Furthermore, MeHA patches loaded with hMSC-EXOs improved the proliferation, migration, angiogenic ability, and expression of specific markers related to wound healing process in human fibroblasts and human endothelial cells.

Keywords: 3D bioprinting; Exosome; Hyaluronic acid derivative; Hydrogel; Patch; Wound dressing.

MeSH terms

  • Endothelial Cells
  • Exosomes* / metabolism
  • Humans
  • Hyaluronic Acid / pharmacology
  • Mesenchymal Stem Cells* / metabolism
  • Wound Healing

Substances

  • Hyaluronic Acid